Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shy, M. E.
Right arrow Articles by Osserman, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shy, M. E.
Right arrow Articles by Osserman, E. F.
NEUROLOGY 1986;36:1429
© 1986 American Academy of Neurology

Motor neuron disease and plasma cell dyscrasia

Michael E. Shy, MD, Lewis P. Rowland, MD, Torben Smith, MD, Werner Trojaborg, MD, Norman Latov, MD, PhD, William Sherman, MD, Michael A. Pesce, PhD, Robert E. Lovelace, MD and E. F. Osserman, MD

Department of Neurology, Columbia University College of Physicians and Surgeons; Neurological Institute of Presbyterian Hospital: H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases; and the General Clinical Research Center of the Columbia-Presbyterian Medical Center.

In the years 1977 to 1984, 10 of 206 patients (4.8%) with motor neuron disease (MND) had M proteins; 4 had IgM and 6 had IgG. Among 100 control patients with other neurologic diseases, only 1 had an M protein. We later added six cases of MND and M proteins, as well as three with polyclonal IgM elevations and two with Bence-Jones proteins. Including other reports, there are now 37 known cases of MND with monoclonal and 5 with polyclonal gammopathy. There is evidence that plasma cell dyscrasia is often undetected; the actual incidence of serum immunoglobulin abnormality in patients with MND may be greater than our figure.

Address correspondence and reprint requests to Dr. Shy, Department of Neurology, Jefferson Medical College, 1025 Walnut Street, Philadelphia, PA 19107.

Supported by the Center Grants from the Muscular Dystrophy Association and NIH (NINCDS-NS11766) and GCRC (RR-00645). Dr. Shy was a recipient of research fellowships from the NINCDS and the Muscular Dystrophy Association.




This article has been cited by other articles:


Home page
BrainHome page
R. M. Van den Berg-Vos, J. Visser, H. Franssen, M. de Visser, J. M. B. V. de Jong, S. Kalmijn, J. H. J. Wokke, and L. H. Van den Berg
Sporadic lower motor neuron disease with adult onset: classification of subtypes
Brain, May 1, 2003; 126(5): 1036 - 1047.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
W.J. Triggs and M.A. Edgar
Case 36-1995- A 61-year-old man with increasing weakness and atrophy of all extremities
N. Engl. J. Med., November 23, 1995; 333(21): 1406 - 1412.
[Full Text] [PDF]


Home page
Arch NeurolHome page
M. C. Dalakas, D. P. Stein, C. Otero, E. Sekul, E. J. Cupler, and S. McCrosky
Effect of High-Dose Intravenous Immunoglobulin on Amyotrophic Lateral Sclerosis and Multifocal Motor Neuropathy
Arch Neurol, September 1, 1994; 51(9): 861 - 864.
[Abstract] [PDF]


Home page
Arch NeurolHome page
F. H. Norris, W. Burns, K. S. U, E. Mukai, and H. Norris
Spinal Fluid Cells and Protein in Amyotrophic Lateral Sclerosis
Arch Neurol, May 1, 1993; 50(5): 489 - 491.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. I. Engelhardt and S. H. Appel
IgG Reactivity in the Spinal Cord and Motor Cortex in Amyotrophic Lateral Sclerosis
Arch Neurol, November 1, 1990; 47(11): 1210 - 1216.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
M. A. Duston, M. Skinner, J. Anderson, and A. S. Cohen
Peripheral Neuropathy as an Early Marker of AL Amyloidosis
Arch Intern Med, February 1, 1989; 149(2): 358 - 360.
[Abstract] [PDF]


Home page
Arch NeurolHome page
S. H. Appel, S. S. Stewart, V. Appel, Y. Harati, W. Mietlowski, W. Weiss, and G. W. Belendiuk
A Double-blind Study of the Effectiveness of Cyclosporine in Amyotrophic Lateral Sclerosis
Arch Neurol, April 1, 1988; 45(4): 381 - 386.
[Abstract] [PDF]


Home page
Arch NeurolHome page
H. Mitsumoto, M. R. Hanson, and D. A. Chad
Amyotrophic Lateral Sclerosis: Recent Advances in Pathogenesis and Therapeutic Trials
Arch Neurol, February 1, 1988; 45(2): 189 - 202.
[Abstract] [PDF]


Home page
Arch NeurolHome page
S. J. Zuckerman, M. A. Pesce, L. P. Rowland, W. Sherman, M. E. Shy, N. Latov, and E. F. Osserman
An Alert for Motor Neuron Diseases and Peripheral Neuropathy: Monoclonal Paraproteinemia May Be Missed by Routine Electrophoresis
Arch Neurol, March 1, 1987; 44(3): 250 - 251.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.